BMY Earnings Bristol Myers Squibb
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | 1.31 | 2026-04-30 | 10-Q |
| FY 2025 | 2025-12-31 | 3.46 | 2026-02-11 | 10-K |
| Q3 2025 | 2025-09-30 | 2.93 | 2025-10-30 | 10-Q |
| Q2 2025 | 2025-06-30 | 1.85 | 2025-07-31 | 10-Q |
| Q1 2026 | 2025-03-31 | 1.20 | 2026-04-30 | 10-Q |
| FY 2025 | 2024-12-31 | -4.41 | 2026-02-11 | 10-K |
| Q3 2025 | 2024-09-30 | -4.45 | 2025-10-30 | 10-Q |
| Q2 2025 | 2024-06-30 | -5.05 | 2025-07-31 | 10-Q |
| Q1 2025 | 2024-03-31 | -5.89 | 2025-04-24 | 10-Q |
| FY 2025 | 2023-12-31 | 3.86 | 2026-02-11 | 10-K |
| Q3 2024 | 2023-09-30 | 2.99 | 2024-10-31 | 10-Q |
| Q2 2024 | 2023-06-30 | 2.06 | 2024-07-26 | 10-Q |
| Q1 2024 | 2023-03-31 | 1.07 | 2024-04-25 | 10-Q |
| FY 2024 | 2022-12-31 | 2.95 | 2025-02-12 | 10-K |
| Q3 2023 | 2022-09-30 | 2.00 | 2023-10-26 | 10-Q |
| Q2 2023 | 2022-06-30 | 1.25 | 2023-07-27 | 10-Q |
| Q1 2023 | 2022-03-31 | 0.59 | 2023-04-27 | 10-Q |
| FY 2023 | 2021-12-31 | 3.12 | 2024-02-13 | 10-K |
| Q3 2022 | 2021-09-30 | 2.05 | 2022-10-26 | 10-Q |
| Q2 2022 | 2021-06-30 | 1.36 | 2022-07-27 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.